Latest Breaking News On - Marcus snow - Page 6 : comparemela.com

Save Billions or Stick with Humira? Drug Brokers Steer Americans to the Costly Choice

Save Billions or Stick with Humira? Drug Brokers Steer Americans to the Costly Choice
healthleadersmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthleadersmedia.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNew yorkKaiser permanenteAlex jungJuliana reedAntonio ciacciaKevin aliMadelaine feldmanArthur allenMark cubanMichael thompsonCoherus biosciencesRachel shubertCora opsahlGreg baker

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Makers of biosimilars must still work within a health care system in which basic economics rarely seems to hold sway.

United statesUnited kingdomNew yorkAlex jungKaiser permanenteMichael thompsonKeith athowCora opsahlPaul holmesGreg bakerCoherus biosciencesAntonio ciacciaMadelaine feldmanRichard gonzalezMary beth langSiddharth singh

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Thousands of patients with autoimmune diseases who rely on Humira could get financial relief from new low-cost rivals if pharmacy benefit managers would get on board.

New yorkUnited statesSan franciscoUnited kingdomMark cubanMadelaine feldmanKeith athowMichael thompsonDavid paul morris bloombergMary beth langKaiser permanenteKevin aliAntonio ciacciaRichard gonzalezAlex jungGavin newsom

What You Need to Know About Humira s Low-Cost Competitors

Seven Humira biosimilars became available in July with promises of giving patients more low-cost adalimumab options.

United statesUniversity of nebraska medical centerKyle skiermontAlex brillMarcus snowNebraska medical centerAmerican collegePatient switchNebraska medicineBiosimilars cut drug costsMatrix global advisors

After Yusimry s Discount, Future Adalimumab Pricing Unclear

SmithRx, which bills itself as "next-generation pharmacy benefits management," announced that it will offer Yusimry to its members at a discount of more than 90%.

Jake frenzSteven horvitzCoherus biosciencesDennis lanfearMark cubanDrug administrationUniversity of nebraska medical centerCost plus drug companyMark cuban cost plus drug companyAnalytics groupMarcus snowNebraska medical centerCost plus drugs